Home / Private raises / Zai Lab Ltd
Zai Lab Ltd
Biotechnology · Cambridge, Massachusetts · $250M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-09 | D (new) | $250M | $250M | 25 | 506(b) | Equity | Oct 27 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Sold through (placement agents)
| Broker-dealer | Solicited in |
|---|---|
| LEERINK PARTNERS LLC | All States |
Sales commissions $7.5M in the latest filing.
Issuer
| Industry | Biotechnology |
| Located | Cambridge, Massachusetts |
| Entity | Other |
| Incorporated | Cayman Islands |
| SEC CIK | 1704292 |
People named in the latest filing
| Name | Role |
|---|---|
| SAMANTHA (YING) DU, Ph.D. | Executive Officer, Director |
| JOHN DAVID DIEKMAN, Ph.D. | Director |
| RICHARD BRIAN GAYNOR, M.D. | Director |
| NISA BERNICE WING-YU LEUNG | Director |
| WILLIAM DAVID LIS | Director |
| SCOTT WILLIAM MORRISON | Director |
| LEON OLIVER MOULDER, JR. | Director |
| MICHEL PERICLES VOUNATSOS | Director |
| PETER KARL WIRTH, J.D. | Director |
| YAJING CHEN, Ph.D. | Executive Officer |
| RAFAEL G. AMADO, M.D. | Executive Officer |
| F. TY EDMONDSON, J.D. | Executive Officer |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
